Hat-trick multibaggers! These 4 stocks have been giving over 100% annual return in last 3 years
After more than doubling for two consecutive years in 2020 and 2021, shares of speciality chemical player Jyoti Resins & Adhesives have gone up 3 times in 2022. Since last year, the stock has been rising continuously with higher highs and higher lows. On the weekly chart, the smallcap stock has not faced any major profit booking after 2021.
26 smallcap stocks turned multibagger in 2022. Did you miss the rally?
Sectoral analysis of the winners of 2022 shows that Nifty PSU Bank index and Nifty CPSE index have been the top two gainers of the year with an upside of 65% and 19.5%, respectively, so far. On the other hand, the IT index has been the top wealth eroder and has so far lost over one-fourth of its value.
Dalal Street veterans added these stocks in Q1. Do you own any?
Marquee investor Dolly Khanna remained busy shopping as she clinched as many as half a dozen new shares, including a few multibaggers.She picked up 48.7 lakh shares or a 3.3 per cent stake in Chennai Petrochem worth Rs 139.2 crore, whereas 18.8 lakh shares or 1.1 per cent stake in Manali Petrochem worth Rs 19.6 crore.
Chennai-based Dolly Khanna, whose portfolio is managed by her husband Rajiv Khanna, picked up stocks such as Chennai Petroleum Corporation, National Oxygen and Monte Carlo Fashions. Chennai Petroleum surged 145% in the June quarter amid rising crude oil prices.
Corporate Radar: Dividend; Q4 results, bonus, stock splits and more
Visaka Industries, Ashirwad Steels & Industries and CIL Securities will have their annual general meetings while Jagsonpal Pharmaceuticals and Syschem (India) will have their EGMs today.Avantel will go ex-bonus today in the ratio of 3:1. The board of Sheela Foam will consider an ESOP.
⭐️Target 1 achieved in JAGSNPHARM. Gain of 67% Target 2 is ON..⭐️
Breakout chart as well as follow up chart added for reference. Charts are self explanatory. Entry, Targets and Trailing Stop Loss are mentioned on the chart.
#JAGSNPHARM : JAGSNPHARM was suggested at 227-228 on my post dated 22nd Feb 2022. Now trading at 253. hope you enjoyed this call. more uptrend expected
#JAGSNPHARM : Jagsonpal pharma was suggested yesterday at 227-228 level. today touched 265-267. hope you enjoyed this view. keep following me for my regular stock updates
#JAGSNPHARM : Jagsonpal Pharma has given bullish breakout when it crossed above 190. Today its trading at 228. Looking very strong on chart for further short term uptrend